SC 13G/A: Corbus Pharmaceuticals Holdings, Inc.

AI Summary

SC 13G/A filing by Corbus Pharmaceuticals Holdings, Inc..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.0001 — me of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securitie

Filing Documents

• p24-3154sc13ga.htm (SC 13G/A) — 53KB
• 0000902664-24-006642.txt ( ) — 55KB

(a)

Item 1(a). Name of Issuer. Corbus Pharmaceuticals Holdings, Inc. (the " Issuer ").

(b)

Item 1(b). Address of Issuer's Principal Executive Offices. 500 River Ridge Drive, Norwood, MA 02062.

(a)

Item 2(a). Name of Person Filing. This statement is filed by: (i) Point72 Asset Management, L.P. (" Point72 Asset Management ") with respect to shares of common stock, par value $0.0001 per share (" Shares "), of the Issuer that were held by an investment fund it manages; (ii) Point72 Capital Advisors, Inc. (" Point72 Capital Advisors Inc .") with respect to Shares that were held by an investment fund managed by Point72 Asset Management; and (iii) Steven A. Cohen (" Mr. Cohen ") with respect to Shares that were beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc.

(b)

Item 2(b). Address of Principal Business Office. The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902.

(c)

Item 2(c). Place of Organization. Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen.

(d)

Item 2(d). Title of Class of Securities. Common Stock, par value $0.0001 per share.

(e)

Item 2(e). CUSIP Number. 21833P301 Item 3. If this Statement is Filed Pursuant to §§ 240.13d-1(b) or 240.13d-2(b), or (c), check whether the Person Filing is a: Not applicable. Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each Reporting Person. Such information is as of the close of business on September 30, 2024. Item 5. If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [X]. CUSIP No. 21833P301 13G/A Page 6 of 7 Pages Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. By signing below each Reporting Person certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. CUSIP No. 21833P301 13G/A Page 7 of 7 Pages SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: November 14, 2024 POINT72 ASSET MANAGEMENT, L.P. By: /s/ Jason M. Colombo Name: Jason M

View Full Filing

View this SC 13G/A filing on SEC EDGAR